Search Results - "Muzi, Paola"
-
1
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
Published in Journal of cancer research and clinical oncology (01-07-2021)“…Purpose Human tau is a highly dynamic, multifunctional protein expressed in different isoforms and conformers, known to modulate microtubule turnover. Tau…”
Get full text
Journal Article -
2
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
Published in The Prostate (01-09-2015)“…BACKGROUND The majority of prostate cancer (Pca) patient morbidity can be attributed to bone metastatic events, which poses a significant clinical obstacle…”
Get full text
Journal Article -
3
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
Published in Endocrine-related cancer (01-06-2009)“…One of the major obstacles in the treatment of hormone-refractory prostate cancer (HRPC) is the development of chemoresistant tumors. The aim of this study is…”
Get full text
Journal Article -
4
Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models
Published in Anti-cancer agents in medicinal chemistry (01-01-2014)“…α-Methylacyl-CoA racemase (AMACR) participates in the oxidation of branched chain fatty acids and is highly expressed in prostate cancer (PCa). The aims of…”
Get more information
Journal Article -
5
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
Published in Endocrine-related cancer (01-03-2006)“…The activation of epidermal growth factor receptor (EGF-R) plays a key role in the promotion of proliferation and invasion in prostatic carcinoma (PCa)…”
Get full text
Journal Article -
6
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination
Published in Thrombosis and haemostasis (01-05-2005)“…Urokinase-type plasminogen activator receptor (uPAR) and Epidermal Growth Factor Receptor (EGFR) are ubiquitous receptors involved in the control of a variety…”
Get more information
Journal Article -
7
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer
Published in Endocrine-related cancer (01-09-2007)“…Bicalutamide monotherapy is emerging as an alternative in the treatment of locally advanced prostate cancer. However, a significant number of these patients…”
Get full text
Journal Article -
8
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells
Published in Endocrine-related cancer (01-03-2008)“…Diets high in n-6 fatty acids are associated with an increased risk of bone metastasis from prostate carces (PCa). The molecular mechanism underlying this…”
Get full text
Journal Article -
9
Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats
Published in World journal of gastroenterology : WJG (28-09-2005)“…AIM: To evaluate the role of nitric oxide (NO) in the motor disorders of the dilated uninflamed mid-colon (DUMC) from trinitrobenzene sulfonic acid…”
Get full text
Journal Article -
10
TLR4 and TLR9 Expression in Different Phenotypes of Rhinitis
Published in International Journal of Otolaryngology (01-01-2012)“…Background. Toll-like receptors (TLRs) represent a family of evolutionarily conserved proteins, that represent a fundamental link between innate and adaptive…”
Get full text
Journal Article -
11
Psychoneuroendocrinoimmunology-based meditation (PNEIMED) training reduces salivary cortisol under basal and stressful conditions in healthy university students: Results of a randomized controlled study
Published in Explore (New York, N.Y.) (01-05-2020)“…Meditation represents an effective and safe practice to lower distress and promote well-being. PsychoNeuroEndocrinoImmunology-based Meditation (PNEIMED) is a…”
Get full text
Journal Article -
12
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells
Published in Oncology reports (01-03-2013)“…DNA methylation might be the earliest somatic genome changes in prostate cancer that also play an important role in the process of tumor invasion, growth and…”
Get full text
Journal Article -
13
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer
Published in Endocrine-related cancer (01-06-2013)“…Aberrant activation or ‘reactivation’ of androgen receptor (AR) during androgen ablation therapy shows a potential cause for the development of…”
Get full text
Journal Article -
14
Pyrazolo[3,4- d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells
Published in European journal of cancer (1990) (01-11-2006)“…During its biological progression, prostate cancer frequently develops dependence on growth factor receptors and their downstream signalling messengers,…”
Get full text
Journal Article -
15
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models: CXCR4 Inhibition Has Anti-Tumor and Anti-Metastatic Effects in Prostate Cancer Models
Published in The Prostate (01-07-2015)Get full text
Journal Article -
16
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro
Published in International journal of oncology (01-01-2007)“…In the prostate, cellular growth and differentiation are finely regulated by a complex interaction between stromal and epithelial cells under the control of…”
Get full text
Journal Article -
17
Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors
Published in The Prostate (15-06-2008)“…BACKGROUND PTEN is a well‐characterized tumor suppressor that negatively regulates cell growth and survival through the modulation of PI3K/Akt pathway. METHODS…”
Get full text
Journal Article -
18
Abstract 3440: CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce the incidence of tumor spreading and improve overall survival in preclinical models of prostate cancer
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract Background: CRM1 (XPO1) is the exclusive exportin mediating transport of most tumor suppressor proteins (TSPs) including p53, pRb, FOXO, APC and p21…”
Get full text
Journal Article -
19
Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386
Published in The Journal of urology (01-07-2008)“…The profound decrease in serum dihydrotestosterone observed with the dual 5alpha-reductase inhibitor dutasteride makes it an attractive agent for prostate…”
Get more information
Journal Article -
20
Her2 crosstalks with TrkA in a subset of prostate cancer cells: Rationale for a guided dual treatment
Published in The Prostate (01-03-2009)“…BACKGROUND To date, no effective therapeutic treatment prevents prostate cancer (PCa) progression to more advanced and invasive disease forms. It has been…”
Get full text
Journal Article